First Ebola Vaccine Dose Administered to Volunteer
Summary
Oxford University has administered the first dose of a new vaccine against the Bundibugyo strain of Ebola to a volunteer, aiming to combat the deadly epidemic in Congo and Uganda.
Key Points
- Oxford University administered the first dose of a new Ebola vaccine to a volunteer in Oxford.
- The vaccine targets the Bundibugyo species of Ebola causing an epidemic in Democratic Republic of Congo and Uganda.
- The vaccine is based on the same technology as AstraZeneca's COVID-19 vaccine and was developed rapidly in eight weeks.
- World Health Organization reports over 1000 deaths from this Ebola outbreak, the fastest spreading of its kind in recent months.
